We are delighted to announce that submissions are now open for the ACTA 2024 Clinical Trials and Registries Symposium on Monday 2nd & Tuesday 3rd December and the Clinical Registries Symposium and Workshops on Tuesday 3rd and Wednesday 4th December.
We invite authors to submit abstracts for both oral and poster presentations within the 2024 themes.
This years theme is Effective, together.
We invite abstracts that address the following themes:
- Innovations in Trials
- Building Successful Collaborations
- Consumer Engagement and Involvement
- Underrepresented Populations
- Data Enabled Trials
- Innovations in Registries
Submissions can be made through the relevant Submission Portal below.
** The ACTA 2024 Symposium and the Clinical Registries Symposium and Workshop Portals will be open to accept late Abstract Submissions until 12pm today, Tuesday 17th September 2024 **
Tuesday 2nd July
- Submissions Open
Tuesday 17th September
- Submissions Close at 12pm
Monday 14th October
- Author Notification
Abstract Submissions that are accepted will qualify for
registration at the early bird rate.
ACTA 2024 Clinical Trials and Registries Symposium - Monday 2nd & Tuesday 3rd December
If you are ready to submit an oral or poster presentation for the ACTA 2024 Clinical Trials and Registries Symposium, click on the ACTA 2024 Submission Portal link below and follow the instructions to complete your submission.
Clinical Registries Symposium and Workshops - Tuesday 3rd and Wednesday 4th December
If you are ready to submit a Workshop, Oral or Poster submission for the Clinical Registries Symposium and Workshops, click on the Clinical Registries Workshop & Symposium Portal below and follow the instructions to complete your submission.
Workshop Submissions Only
Please ensure you download the below Clinical Registries Workshop form and attach as a supporting document, along with your submission.
Clinical Registries Workshop Form (pdf)
DownloadClinical Registries Workshop Eligibility Criteria
Please download and review the Clinical Registries Eligibility Criteria prior to submitting your abstract.
Eligibility Criteria Form (pdf)
DownloadSubmit your completed abstract through the portal link above. Please do not include symbols, tables, pictures or diagrams within the ‘content’ of your abstract to avoid formatting errors.
You will receive an email acknowledging receipt of your submission.
** The ACTA 2024 Symposium Portal and the Clinical Registries Symposium and Workshop Portal will close on Tuesday 17th September at 12.00pm **
Length
Maximum 300 words (excluding references)
Title
Limited to 20 words in sentence case (i.e. capital letters are used for the first letter of the first work and proper nouns; all other words are lower case.
Author and Co-Authors’ details
Include all authors. The first author will be presumed to be the presenting author unless otherwise specified at abstract submission.
Required abstract structure
Organise the abstract as follows:
- Aim (State concisely why the study was conducted)
- Method (Indicate the locale, sample number, principal test(s) performed, and the types of statistical analysis employed)
- Results (Confirm or refute the hypothesis, supported by statistics if appropriate)
- Conclusion (State the effect of the study on future patient management or the understanding of basic processes)
- References (Include up to 3 references if applicable)
Oral and Poster Presentations
ACTA Members:
Oral presentations are usually 15 minutes, or as appropriate for the program.
Posters:
Poster presentations will be accepted at this years conference.
Audio Visual
Each meeting room will be equipped for the presentation of PowerPoint slides and include a data projector, laptop, lectern and microphone. Multimedia clips should be embedded in your slides. Other audio-visual aids, such as overhead projectors, are not available.
All presentations must be digital in either PowerPoint or Keynote. Speakers will be required to bring their presentations on a USB stick with them to the conference. Presentations must be given at least three (3) hours prior to the start of the session in which you are presenting. It is not good practice changing computer connections at the lectern so presenting on your own laptop is not permitted.
Submissions
All abstracts are to be submitted via the abstract submission portal. Please do not include symbols, tables, pictures or diagrams within the ‘content’ of your abstract to avoid formatting errors.
Submissions sent via email will not be accepted.
Selection and Notification
The ACTA 2024 Clinical Trials and Registries Symposium Convener serves as the head of the Steering Committee and will make the final decision on which abstracts are accepted.
Abstracts will be reviewed against the following criteria:
- Completed rather than future work (i.e. final results)
- Original data of high quality
- An analysis that extends existing knowledge
- Diversity and consumer involvement
- Clarity of methodology, analysis and presentation of results
- Specific rather than general findings
Results of the abstract review will be sent to the contact author by 14th October 2024. Presenting authors will be notified after the closing date regarding the status of their abstract.
All presenters will be required to register for the conference and pay the appropriate registration fees should they be selected.
All presenters need to meet their own travel and accommodation costs.
* Please note that all successful delegates presenting abstracts are required to register under the relevant delegate category for the event. A 15% discount code will be provided upon acceptance of your abstract which will allow you to register at the discounted rate regardless of your registration date.
We use cookies to analyse website traffic and optimise your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.